论文部分内容阅读
目的对参麦注射液联合生长抑素治疗急性胰腺炎患者的疗效进行分析。方法选取急性胰腺炎患者80例,分为两组,对照组患者给予生长抑素治疗,实验组在对照组治疗基础上联合使用参麦注射液。结果实验组血清淀粉酶、C-反应蛋白、肿瘤坏死因子-α三项指标水平下降幅度大于对照组,治疗总有效率为97.5%,对照组有效率为75%。结论参麦注射液联合生长抑素治疗急性胰腺炎的疗效确切,可显著改善患者临床症状,减少并发症,值得在临床上推广应用。
Objective To analyze the curative effect of Shenmai injection combined with somatostatin in patients with acute pancreatitis. Methods Eighty patients with acute pancreatitis were divided into two groups. Patients in the control group were treated with somatostatin. The experimental group was treated with Shenmai injection on the basis of the control group. Results The levels of serum amylase, C-reactive protein and tumor necrosis factor-α in the experimental group decreased more than those in the control group. The total effective rate was 97.5% and that of the control group was 75%. Conclusion Shenmai injection combined with somatostatin in the treatment of acute pancreatitis has definite curative effect, which can significantly improve the clinical symptoms and reduce the complications, which is worth popularizing in clinic.